Applied economics

sort by:

Individual level discrete event simulation taught on the MSc Health Economics and Decision Modelling (based on NICE DSU TSD15 model) in R

software posted on 2025-05-02

Estimating the overall population health effects of uniform pricing, indication-based pricing, and alternative commercial arrangements for new pharmaceuticals in the UK NHS

Estimating the overall population health effects of uniform pricing, indication-based pricing, and alternative commercial arrangements for new pharmaceuticals in the UK NHS

report posted on 2025-04-30

Sheffield Type 2 Diabetes Treatment Model version 4.0: with the GLoW Trial health economic analysis implemented.

software posted on 2025-02-27

How to Share...Models and Code

How to Share...Models and Code

media posted on 2025-02-17

Sheffield Type 2 Diabetes Treatment Model version 3: with the Embedding RCT health economic analyses implemented

Sheffield Type 2 Diabetes Treatment Model version 3: with the Embedding RCT health economic analyses implemented

software posted on 2025-02-12

Modelling of the health and economic impacts of alcohol and tobacco tax policy in England: Autumn Budget 2024

Modelling of the health and economic impacts of alcohol and tobacco tax policy in England: Autumn Budget 2024

report posted on 2024-11-14

Evaluation of risk stratified breast cancer screening regimens that employ artificial intelligence driven short-term risk assessment

Evaluation of risk stratified breast cancer screening regimens that employ artificial intelligence driven short-term risk assessment

report posted on 2024-10-02

Analysis code associated with project "The effect of proportional pricing on hypothetical alcohol purchasing in two online experiments"

software posted on 2024-09-03

Identification of tax options for high fat, sugar and salt foods and non-alcoholic beverages: Results of a rapid review for the HEALTHEI project

Identification of tax options for high fat, sugar and salt foods and non-alcoholic beverages: Results of a rapid review for the HEALTHEI project

report posted on 2024-08-07

Low Use Homes in Sheffield

Low Use Homes in Sheffield

report posted on 2024-07-01

Protocol for a Scoping Review of Collaborative Engagement in Health State Valuation

Protocol for a Scoping Review of Collaborative Engagement in Health State Valuation

workflow posted on 2024-03-20

Techniques for eliciting societal preferences for “severity” for use in health technology assessments

Techniques for eliciting societal preferences for “severity” for use in health technology assessments

report posted on 2024-03-14

Open Research Conversation: Too sensitive to share? Opening up sensitive research

Open Research Conversation: Too sensitive to share? Opening up sensitive research

media posted on 2024-03-14

collection:
EEPRU

posted on 2024-02-20

Estimating an exchange rate between the EQ5D-3L and ASCOT

Estimating an exchange rate between the EQ5D-3L and ASCOT

report posted on 2024-02-16

Ethnicity, socio-economic status and health

Ethnicity, socio-economic status and health

report posted on 2024-02-16

A general modelling framework to estimate the impact of waiting times on health for patients undergoing elective procedures in the NHS in England

A general modelling framework to estimate the impact of waiting times on health for patients undergoing elective procedures in the NHS in England

report posted on 2024-02-16

Elective surgery waiting time prioritisation to improve population health gains and reduce health inequalities

Elective surgery waiting time prioritisation to improve population health gains and reduce health inequalities

report posted on 2024-02-16

Final report for the technology evaluation of cefiderocol for treating severe aerobic Gram-negative bacterial infections

Final report for the technology evaluation of cefiderocol for treating severe aerobic Gram-negative bacterial infections

report posted on 2024-02-16

Estimating the cost-effectiveness of risk stratified breast cancer screening in the UK

Estimating the cost-effectiveness of risk stratified breast cancer screening in the UK

report posted on 2024-02-16

Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections

Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections

report posted on 2024-02-16

Achieving dynamic efficiency in pharmaceutical innovation: identifying the optimal share of value, the payments required and evaluating pricing policies

Achieving dynamic efficiency in pharmaceutical innovation: identifying the optimal share of value, the payments required and evaluating pricing policies

report posted on 2024-02-16

A literature review of methods to Measure and value benefits in cost-effectiveness analyses of interventions for patients with either a short life expectancy or receiving palliative care

A literature review of methods to Measure and value benefits in cost-effectiveness analyses of interventions for patients with either a short life expectancy or receiving palliative care

report posted on 2024-02-16

Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from an English population study

Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from an English population study

report posted on 2024-02-16

Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13

Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13

report posted on 2024-02-16

Quality review of a proposed EQ5D-5L value set for England

Quality review of a proposed EQ5D-5L value set for England

report posted on 2024-02-16

FRAMEWORK FOR VALUE ASSESSMENT OF NEW ANTIMICROBIALS: Implications of alternative funding arrangements for NICE Appraisal

FRAMEWORK FOR VALUE ASSESSMENT OF NEW ANTIMICROBIALS: Implications of alternative funding arrangements for NICE Appraisal

report posted on 2024-02-16

Health opportunity costs: assessing the implications of uncertainty using elicitation methods with experts

Health opportunity costs: assessing the implications of uncertainty using elicitation methods with experts

report posted on 2024-02-16

PREVALENCE AND ECONOMIC BURDEN OF MEDICATION ERRORS IN THE NHS IN ENGLAND: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK

PREVALENCE AND ECONOMIC BURDEN OF MEDICATION ERRORS IN THE NHS IN ENGLAND: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK

report posted on 2024-02-16

ACE: Economic Evaluation of the Proactive Lung Cluster

ACE: Economic Evaluation of the Proactive Lung Cluster

report posted on 2024-02-16

Whole pathway modelling of depression in patients with diabetes (theme 2: mental health) part 1: executive summary, introduction, clinical reviews and conceptual modelling

Whole pathway modelling of depression in patients with diabetes (theme 2: mental health) part 1: executive summary, introduction, clinical reviews and conceptual modelling

report posted on 2024-02-16

Evidence for the impact of interventions for, and medicines reconciliation in, problematic polypharmacy: a rapid review of systematic reviews and scoping searches

Evidence for the impact of interventions for, and medicines reconciliation in, problematic polypharmacy: a rapid review of systematic reviews and scoping searches

report posted on 2024-02-16

Excess Treatment Costs (ETC): Estimating the magnitude and distribution of ETC in England to inform policy formulation

Excess Treatment Costs (ETC): Estimating the magnitude and distribution of ETC in England to inform policy formulation

report posted on 2024-02-16

A scoping review on the production of different aspects of quality of health care

A scoping review on the production of different aspects of quality of health care

report posted on 2024-02-16

Development and validation of the recovering quality of life (ReQoL) outcome measures

Development and validation of the recovering quality of life (ReQoL) outcome measures

report posted on 2024-02-16

A framework for conducting economic evaluations when using patient decision aids in health care decision making

A framework for conducting economic evaluations when using patient decision aids in health care decision making

report posted on 2024-02-16

An empirical comparison of wellbeing measures used in UK

An empirical comparison of wellbeing measures used in UK

report posted on 2024-02-16

Economic analysis to support NHS implementation of hepatitis c drugs: scoping study

Economic analysis to support NHS implementation of hepatitis c drugs: scoping study

report posted on 2024-02-16

Economic analysis to support NHS implementation of hepatitis c drugs: prioritisation of the treatment options for patients with chronic hepatitis c at the METAVIR f3 stage

Economic analysis to support NHS implementation of hepatitis c drugs: prioritisation of the treatment options for patients with chronic hepatitis c at the METAVIR f3 stage

report posted on 2024-02-16

Whole pathway modelling of depression in patients with diabetes (theme 2: mental health) appendices

Whole pathway modelling of depression in patients with diabetes (theme 2: mental health) appendices

report posted on 2024-02-16